. 2018 Dec 20;24(1):7. doi: 10.3390/molecules24010007

Table 3.

Pharmacokinetic parameters of oral administration (Mean ± SD, n = 4).

Formulation	T_{max (0–72 h)} (h)	C_{max (0–72 h)} (ng/mL)	AUC_0→t (µg·h/mL)	t_1/2 (h)
Oral	4.9 ± 0.8	48.6 ± 12.1 ^d	0.6 ± 0.2 ^d	11.0 ± 1.9 ^d
NS-PA-L	14.5 ± 0.0	1104.7 ± 162.5 ^a	192.3 ± 21.8 ^a	170.5 ± 16.7 ^a
NS-PB-L	14.5 ± 0.0	518.9 ± 109.7 ^a,†,b	153.2 ± 20.2 ^a,b	222.0 ± 23.3 ^a,b
NS-PC-L	14.5 ± 0.0	685.5 ± 60.9 ^†,c	163.0 ± 29.7 ^c	406.8 ± 34.2 ^b
NS-PB-S	7.0 ± 2.0	189.4 ± 32.5 ^b	98.5 ± 21.2 ^b	208.8 ± 17.4 ^†
NS-PC-S	9.0 ± 2.0	232.9 ± 122.2 ^c	110.2 ± 32.1 ^c	266.9 ± 44.4 ^†
NS-Hα-1	6.0 ± 0.0	218.5 ± 31.9	113.1 ± 14.5	241.5 ± 39.2
NS-Hα-2	7.0 ± 2.0	209.7 ± 24.2 ^d	96.9 ± 9.8 ^d	252.3 ± 48.8 ^d

^†p < 0.1, ^a,b,c,d p < 0.05.